Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:RAD

Rite Aid (RAD) Stock Price, News & Analysis

Rite Aid logo

About Rite Aid Stock (NYSE:RAD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.39
$1.89
52-Week Range
N/A
Volume
5,426 shs
Average Volume
4.16 million shs
Market Capitalization
$34.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rite Aid Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
1st Percentile Overall Score

RAD MarketRank™: 

Rite Aid scored higher than 1% of companies evaluated by MarketBeat, and ranked 208th out of 208 stocks in the retail/wholesale sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Rite Aid.

  • Earnings Growth

    Earnings for Rite Aid are expected to grow in the coming year, from ($4.75) to ($3.35) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Rite Aid is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Rite Aid is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for RAD.
  • Dividend Yield

    Rite Aid does not currently pay a dividend.

  • Dividend Growth

    Rite Aid does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for RAD.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Rite Aid this week, compared to 6 articles on an average week.
  • Search Interest

    Only 2 people have searched for RAD on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Rite Aid insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.58% of the stock of Rite Aid is held by insiders.

  • Percentage Held by Institutions

    Only 34.47% of the stock of Rite Aid is held by institutions.

  • Read more about Rite Aid's insider trading history.
Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

RAD Stock News Headlines

Your blueprint for crypto wealth
The crypto market is heating up, with massive opportunities ahead for those who know where to look. Join us at the Crypto Community Summit to hear from industry experts as they reveal their top picks and predictions for the second half of 2025. Don’t miss out on these must-know secrets that could position your portfolio for explosive growth
See More Headlines

RAD Stock Analysis - Frequently Asked Questions

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share for the quarter, missing the consensus estimate of ($0.77) by $0.47. Rite Aid's quarterly revenue was up .5% on a year-over-year basis.

Rite Aid shares reverse split before market open on Monday, April 22nd 2019.The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Rite Aid subsidiaries include these companies: Bartell Drugs, Envision Pharmaceutical, RediClinic, Health Dialog, Edgehill Drugs, PCS Health Systems, Harco, and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rite Aid investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

Last Earnings
4/20/2023
Today
7/21/2025
Fiscal Year End
2/28/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NYSE:RAD
CIK
84129
Employees
47,000
Year Founded
1968

Profitability

EPS (Trailing Twelve Months)
($17.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$749.94 million
Net Margins
-3.99%
Pretax Margin
-4.02%
Return on Equity
N/A
Return on Assets
-1.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.32
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$24.09 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.36
Book Value
($11.35) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
56,700,000
Free Float
55,800,000
Market Cap
$34.71 million
Optionable
Optionable
Beta
1.25

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:RAD) was last updated on 7/22/2025 by MarketBeat.com Staff
From Our Partners